Beigene Ltd ADR (NQ: BGNE )
194.66
+3.77
(+1.97%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Press Releases about Beigene Ltd ADR
![](https://mms.businesswire.com/media/20221213005484/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://mms.businesswire.com/media/20221209005054/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://mms.businesswire.com/media/20221122005444/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://mms.businesswire.com/media/20221117005394/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://mms.businesswire.com/media/20221115005412/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://mms.businesswire.com/media/20221110005458/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare Blood Cancers
November 10, 2022
From BeiGene
Via Business Wire
![](https://mms.businesswire.com/media/20221108006299/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
BeiGene Reports Third Quarter 2022 Financial Results
November 09, 2022
From BeiGene, Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20221104005187/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
BeiGene to Present at Upcoming Investor Conferences
November 04, 2022
From BeiGene
Via Business Wire
![](https://mms.businesswire.com/media/20221103005526/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://mms.businesswire.com/media/20221102005244/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://mms.businesswire.com/media/20221026005423/en/1612468/5/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg)
![](https://mms.businesswire.com/media/20221014005113/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20221012005491/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20220919005638/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20220919005299/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20220909005536/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20220907006312/en/1199527/5/BGNE_Logo_0821.jpg)
BeiGene to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
September 07, 2022
From BeiGene
Via Business Wire
![](https://mms.businesswire.com/media/20220823005212/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20220815005080/en/1199527/5/BGNE_Logo_0821.jpg)
BeiGene Announces Strategic Alliance with Ontada to Improve U.S. Community Oncology Care
August 15, 2022
From BeiGene
Via Business Wire
![](https://mms.businesswire.com/media/20220809005409/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20220804005380/en/1199527/5/BGNE_Logo_0821.jpg)
BeiGene Reports Second Quarter 2022 Financial Results
August 04, 2022
From BeiGene, Ltd.
Via Business Wire
![](https://mms.businesswire.com/media/20220714005202/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20220713005323/en/1512217/4/ChanLee.jpg)
![](https://mms.businesswire.com/media/20220705005854/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20220630005285/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20220621005659/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20220613005330/en/1199527/5/BGNE_Logo_0821.jpg)
From BeiGene
Via Business Wire
![](https://mms.businesswire.com/media/20220613005329/en/1199527/5/BGNE_Logo_0821.jpg)
![](https://mms.businesswire.com/media/20220610005110/en/1199527/5/BGNE_Logo_0821.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.